Key Highlights:
-
India and China accelerated shipments, increasing supply and pressuring U.S. Simvastatin API prices.
-
Dollar depreciation and uncertain demand led to restrained purchasing behavior.
-
Energy and feedstock prices fell, easing production pressures.
-
Post-summer restocking and policy shifts may drive demand and price recovery in near future.
Pharmaceutical Demand Trends
Import offers for Simvastatin API across the US market during the entire mid Q* softened following similar mixed trajectory for the past few months. Market participants point to a confluence of factors to this including the flowing together of merchant cargo from major Asian suppliers, easing ocean freight cost and cautious buying sentiments that considerably puts offers for Simvastatin API down during the entirely of august ****. However, market players also anticipate a modest rebound in prices yet again in the future, particularly in September as restocking and tightening in upstream supply chains could reassert themselves.
Leave a Comment
Comments (0)